Skip to content

Quercetin Ameliorates Imatinib-Induced Ovarian Damage by Regulating Mitochondrial Dysfunction and PANoptosis via the RAF1-ERK1/2-Drp1 Axis.

Aug 2026 · Free Radical Biology & Medicine · Vol 256, pp. 15-30 · 0 citations
Medicine

TL;DR

In vitro experiments revealed that IMA induced PANoptosis, characterized by membrane blebbing and swelling, pyknosis, as well as rupture of the nuclear and plasma membranes observed, which suppressed IMA-induced PANoptosis, and improved granulosa cell viability and oocyte quality.

View source

Similar papers

Sep 2026

Celastrol induces mitochondrial apoptosis in hepatocellular carcinoma by suppressing LRP6-associated Wnt/β-catenin signaling.

Celastrol, a quinone methide triterpenoid derived from the root bark of Tripterygium wilfordii Hook. f., has antitumor activity, but its molecular mechanisms in hepatocellular carcinoma (HCC) remain incompletely defined. This study investigated whether celastrol suppresses HCC through LRP6-associated modulation of Wnt/...

Yi-Xuan Wang, Dan-Dan Wang, Jing-Hao Fu et al. · 0 citations
Open access Sep 2026

ROS-Activated SHP-1 Signaling Underlies Artesunate-Mediated Inhibition of EMT and STAT3-Driven Prostate Cancer Progression.

Constitutive activation of signal transducer and activator of transcription 3 (STAT3) is a hallmark of prostate cancer (PC) progression. Here, we investigated the anticancer effects of artesunate (ART) and its underlying mechanisms in PC. ART selectively reduced the viability of PC cells with minimal toxicity toward no...

Young Y. Jung, Alamelu Nachiyappan, Na Young Kim et al. · 0 citations
Open access Aug 2026

Marbofloxacin Suppresses Breast Cancer Growth Through Oxidative Stress and Metabolic Reprogramming with Predicted HSP90AA1–EGFR Network Modulation

Background: Drug repurposing represents an accelerated and cost-effective approach to discovering novel oncologic therapeutics. Here, we investigated the anticancer potential and underlying mechanisms of marbofloxacin (MBF), a veterinary fluoroquinolone (FQ), against breast cancer (BC) cells. Methods: The cellular impa...

M. Yavuz, F. R. P. Dewi, Ilknur Keskin et al. · 0 citations
Sep 2026

Rutaecarpine suppresses osteosarcoma progression and tumor-induced bone destruction by targeting the PRAS40-associated signaling network in an ex vivo metastasis model.

Despite advances in current therapeutic strategies, osteosarcoma remains a highly aggressive malignancy with limited treatment options. Rutaecarpine (Rut), an indolopyridoquinazolinone alkaloid with selective cyclooxygenase-2 inhibitory activity, has been reported to possess diverse pharmacological properties; however,...

Hyung-Mun Yun, Kyung-Ran Park · 0 citations
Sep 2026

Acteoside ameliorates doxorubicin-induced cardiotoxicity by suppressing ferroptosis through activation of the KEAP1/NRF2 pathway.

Doxorubicin (DOX)-induced cardiotoxicity (DIC) is a major limitation to the clinical use of DOX, highlighting the need for effective cardioprotective strategies. Although acteoside (ACT), a natural compound with antioxidant properties, has shown potential cardioprotective effects, its role in DIC, particularly in the r...

Meng Wang, Che Wang, Zhi-Hao Liu et al. · 0 citations
Open access Aug 2026

4,4'-dimethoxychalcone induces thermosensitive impairment of SIRT3-associated mitochondrial signaling and apoptotic cell death with therapeutic potential in cancer.

DMC is identified as a thermosensitive inhibitor of SIRT3 and mechanistic insights into its potential to disrupt mitochondrial homeostasis for targeted cancer therapy are provided.

Yu Song, Qing-Li Zhao, Ryohei Ogawa et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.